These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33308153)

  • 1. In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform.
    Russo G; Pennisi M; Fichera E; Motta S; Raciti G; Viceconti M; Pappalardo F
    BMC Bioinformatics; 2020 Dec; 21(Suppl 17):527. PubMed ID: 33308153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets.
    Russo G; Di Salvatore V; Sgroi G; Parasiliti Palumbo GA; Reche PA; Pappalardo F
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34607353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
    Oliveira SC; de Magalhães MTQ; Homan EJ
    Front Immunol; 2020; 11():587615. PubMed ID: 33193414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
    Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
    Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 6. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies.
    Payandeh Z; Mohammadkhani N; Nabi Afjadi M; Khalili S; Rajabibazl M; Houjaghani Z; Dadkhah M
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):899-910. PubMed ID: 33307883
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
    Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
    Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.
    Sultana J; Mazzaglia G; Luxi N; Cancellieri A; Capuano A; Ferrajolo C; de Waure C; Ferlazzo G; Trifirò G
    Expert Rev Vaccines; 2020 Oct; 19(10):919-936. PubMed ID: 32940090
    [No Abstract]   [Full Text] [Related]  

  • 10. One Shot Wonder: A Vaccine Against All Coronaviruses.
    Mertz L
    IEEE Pulse; 2020; 11(6):2-5. PubMed ID: 33315546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccines: ethical framework concerning human challenge studies.
    Calina D; Hartung T; Docea AO; Spandidos DA; Egorov AM; Shtilman MI; Carvalho F; Tsatsakis A
    Daru; 2020 Dec; 28(2):807-812. PubMed ID: 32851596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2.
    Behmard E; Soleymani B; Najafi A; Barzegari E
    Sci Rep; 2020 Nov; 10(1):20864. PubMed ID: 33257716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming vaccine development.
    Black S; Bloom DE; Kaslow DC; Pecetta S; Rappuoli R
    Semin Immunol; 2020 Aug; 50():101413. PubMed ID: 33127296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS).
    Pennisi M; Russo G; Sgroi G; Bonaccorso A; Parasiliti Palumbo GA; Fichera E; Mitra DK; Walker KB; Cardona PJ; Amat M; Viceconti M; Pappalardo F
    BMC Bioinformatics; 2019 Dec; 20(Suppl 6):504. PubMed ID: 31822272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunity against SARS-CoV-2: walking to the vaccination].
    Rodríguez Hernández C; Sanz Moreno L
    Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of COVID-19.
    Brüssow H
    Environ Microbiol; 2020 Dec; 22(12):4895-4908. PubMed ID: 33145867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A COVID-19 vaccine-dare to dream.
    Phillis A
    Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
    Bennet BM; Wolf J; Laureano R; Sellers RS
    Toxicol Pathol; 2020 Oct; 48(7):800-809. PubMed ID: 32926660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward.
    Iserson KV
    Camb Q Healthc Ethics; 2021 Jan; 30(1):59-68. PubMed ID: 32498742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lightning-fast quest for COVID vaccines - and what it means for other diseases.
    Ball P
    Nature; 2021 Jan; 589(7840):16-18. PubMed ID: 33340018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.